Elizabeth E. Reed, SVP, GC & Corporate Secretary at Travere Therapeutics, Inc. (TVTX), sold 1,950 shares at $21.51 ($42K) on 2022-05-12, disclosed to the SEC on 2022-05-12.
Scheduled sale ($42k) by SVP, GC & Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.51 | 900 | $19K | 46.2% |
| 2 | $21.51 | 1,050 | $23K | 53.8% |
| Total | $21.51 avg | 1,950 | $42K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.1M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-03-18 | $562K | — | Filing → |